Key facts
- Notable investors include FJ Labs.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Blend Compounding
- ·The full record, as it builds
Funding rounds
No funding rounds for Blend Compounding are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Blend Compounding
Operator of a wellness firm intended to specialise in non-prescription compounding pharmacy formulations. The company provides pharmacist-led service for people seeking more effective support than standard over-the-counter and off-the-shelf products, without the need, time or cost of seeing a GP or specialist to get a script, enabling pharmacists to confirm suitability and answer any questions you may have.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Columbus, OH, United States
- Founded
- 2024
- Website
- blendcompounding.com/
- Ownership
- Privately Held (backing)
Blend Compounding doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Blend Compounding shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Blend Compounding in its N-PORT filings yet. We sweep new filings monthly.